10 20 30 40 50 60 70 80 1Y32 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER UNKNOWN FUNCTION 23-NOV-04 1Y32
TITLE NMR STRUCTURE OF HUMANIN IN 30% TFE SOLUTION
COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMANIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: HUMANIN WAS PREPARED BY FMOC-SOLID PHASE SOURCE 4 SYNTHESIS ON -CL-TRITYL-AMIDOMETHYL POLYSTYRENE RESIN. THE SOURCE 5 PEPTIDE WAS PURIFIED TO 95% WITH SEMI-PREPARATIVE RP-HPLC SOURCE 6 AND SUITABLY CHARACTERIZED. EVANGELOU, A., ZIKOS, C., SOURCE 7 LIVANIOU, E., AND EVANGELATOS, G.P. (2004) HIGH-YIELD, SOURCE 8 SOLID-PHASE SYNTHESIS OF HUMANIN, AN ALZHEIMER S DISEASE SOURCE 9 ASSOCIATED, NOVEL 24-MER PEPTIDE WHICH CONTAINS A SOURCE 10 DIFFICULT SEQUENCE, J. PEPTIDE SCIENCE 10, 631-635.
KEYWDS HUMANIN, NMR SOLUTION STRUCTURE, ALZHEIMER'S DISEASE, KEYWDS 2 NEUROPROTECTION, UNKNOWN FUNCTION
EXPDTA SOLUTION NMR
NUMMDL 14
AUTHOR D.BENAKI,C.ZIKOS,A.EVANGELOU,E.LIVANIOU,M.VLASSI,E.MIKROS, AUTHOR 2 M.PELECANOU
REVDAT 2 24-FEB-09 1Y32 1 VERSN REVDAT 1 22-FEB-05 1Y32 0
JRNL AUTH D.BENAKI,C.ZIKOS,A.EVANGELOU,E.LIVANIOU,M.VLASSI, JRNL AUTH 2 E.MIKROS,M.PELECANOU JRNL TITL SOLUTION STRUCTURE OF HUMANIN, A PEPTIDE AGAINST JRNL TITL 2 ALZHEIMER'S DISEASE-RELATED NEUROTOXICITY. JRNL REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 329 152 2005 JRNL REFN ISSN 0006-291X JRNL PMID 15721287 JRNL DOI 10.1016/J.BBRC.2005.01.100
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1Y32 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-NOV-04. REMARK 100 THE RCSB ID CODE IS RCSB031053.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 280 REMARK 210 PH : 2.7; 2.7 REMARK 210 IONIC STRENGTH : 60 MICROM SODIUM AZIDE; 60 REMARK 210 MICROM SODIUM AZIDE REMARK 210 PRESSURE : AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : NMR STUDIES OF HUMANIN WERE REMARK 210 CARRIED OUT IN H2O/TFE-D3 7:3 REMARK 210 SOLUTION CONTAINING 60 MICROM REMARK 210 NAN3 AT 280 AND 298 K. THE REMARK 210 CONCENTRATION OF THE SAMPLE REMARK 210 WAS 1.7 MM AND THE PH OF THE REMARK 210 SOLUTION WAS 2.7 (UNCORRECTED REMARK 210 FOR THE PRESENCE OF TFE). REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY, 2D TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 2.6, SPARKY 3, CNS 1.1 REMARK 210 METHOD USED : SIMULATED ANNEALING TORSION REMARK 210 ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 300 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 14 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES.
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 2 88.34 60.12 REMARK 500 1 SER A 14 -46.43 -130.50 REMARK 500 1 LYS A 21 -39.67 -178.02 REMARK 500 2 ARG A 22 43.46 -177.54 REMARK 500 2 ARG A 23 -76.39 -155.88 REMARK 500 3 SER A 14 -46.24 -130.66 REMARK 500 4 SER A 14 -46.26 -132.01 REMARK 500 4 LYS A 21 -174.92 57.73 REMARK 500 4 ARG A 22 -45.93 -131.50 REMARK 500 4 ARG A 23 -51.85 -173.86 REMARK 500 5 LYS A 21 -49.64 -152.92 REMARK 500 5 ARG A 22 -72.27 -154.68 REMARK 500 6 ALA A 2 153.55 61.48 REMARK 500 6 SER A 14 -46.30 -134.47 REMARK 500 7 ALA A 2 92.87 60.98 REMARK 500 7 SER A 14 -46.29 -131.23 REMARK 500 7 LYS A 21 -78.04 63.20 REMARK 500 7 ARG A 22 -79.43 64.19 REMARK 500 7 ARG A 23 -177.99 -177.91 REMARK 500 8 ALA A 2 162.74 60.54 REMARK 500 8 ARG A 23 -70.33 -155.18 REMARK 500 10 ALA A 2 88.21 -166.33 REMARK 500 10 LYS A 21 80.30 60.38 REMARK 500 11 LEU A 10 -75.77 -54.89 REMARK 500 11 SER A 14 -46.27 -135.96 REMARK 500 11 VAL A 20 77.65 43.18 REMARK 500 11 LYS A 21 103.66 69.19 REMARK 500 11 ARG A 22 -63.58 -148.11 REMARK 500 11 ARG A 23 104.62 59.58 REMARK 500 12 VAL A 20 33.08 -92.50 REMARK 500 12 ARG A 22 -56.46 -135.62 REMARK 500 13 LYS A 21 156.66 176.20 REMARK 500 13 ARG A 22 -64.14 -152.55 REMARK 500 13 ARG A 23 -71.00 -164.12 REMARK 500 14 VAL A 20 32.56 -93.68 REMARK 500 14 ARG A 22 46.05 -94.39 REMARK 500 REMARK 500 REMARK: NULL
DBREF 1Y32 A 1 24 UNP Q8IVG9 HUNIN_HUMAN 1 24
SEQRES 1 A 24 MET ALA PRO ARG GLY PHE SER CYS LEU LEU LEU LEU THR SEQRES 2 A 24 SER GLU ILE ASP LEU PRO VAL LYS ARG ARG ALA
HELIX 1 1 PRO A 3 ILE A 16 1 14
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000